Online citations, reference lists, and bibliographies.
← Back to Search

Anandamide Metabolism By Fatty Acid Amide Hydrolase In Intact C6 Glioma Cells. Increased Sensitivity To Inhibition By Ibuprofen And Flurbiprofen Upon Reduction Of Extra- But Not Intracellular PH

S. Holt, C. Fowler
Published 2003 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The metabolism of anandamide by fatty acid amidohydrolase (FAAH) at different intra- and extracellular pH values has been investigated in intact C6 rat glioma cells. The cellular uptake of anandamide at 37°C was found to decrease by 28% when the extracellular pH (pHe) was reduced from pH 7.4 to pH 6.2. In contrast, a selective decrease in intracellular pH (pHi), accomplished by acidifying the cells followed by incubation in sodium-free buffer at pH 7.4, did not affect the uptake. Anandamide uptake was inhibited by (R)-ibuprofen, with pI50 values of 3.05±0.57, 3.66±0.23 and 3.94±0.88 at pHe values of 7.4, 6.8 and 6.2, respectively. In the presence of phenylmethylsulfonyl fluoride, however, (R)-ibuprofen failed to inhibit the uptake of anandamide. A reduction in pHe from 7.4 to 6.2 produced a 17% reduction in the FAAH-catalyzed metabolism of anandamide in the intact C6 cells. However, an increased sensitivity of FAAH activity to inhibition by (R)-ibuprofen as well as (R,S)-flurbiprofen and (S)-flurbiprofen was seen at a lower pHe. For (R)-ibuprofen, pI50 values of 3.57±0.08, 4.04±0.05 and 4.59±0.04 were found at pHe values of 7.4, 6.8 and 6.2, respectively. For (R,S)- and (S)-flurbiprofen, the pI50 values at pHe 7.4 were 4.02±0.05 and 4.13±0.18, respectively at a pHe of 7.4, and 4.81±0.11 and 4.84±0.10, respectively, at a pHe of 6.2. In contrast, intracellular acidification did not affect either the rate of anandamide metabolism or its inhibition by (R)-ibuprofen or (S)-flurbiprofen. It is concluded that a reduction of extracellular pH produces an enhanced accumulation of the acidic NSAIDs ibuprofen and flurbiprofen into C6 glioma cells and thereby an inhibition of anandamide metabolism.
This paper references
10.1046/j.1471-4159.1997.69020631.x
Accumulation of N‐Arachidonoylethanolamine (Anandamide) into Cerebellar Granule Cells Occurs via Facilitated Diffusion
C. Hillard (1997)
10.1038/372686A0
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
V. Marzo (1994)
10.1016/0005-2760(95)00087-S
Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain.
C. Hillard (1995)
10.1016/S0014-5793(00)02082-2
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity
L. De Petrocellis (2000)
10.1073/pnas.161191698
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
B. Cravatt (2001)
10.1002/GLIA.440120305
Intracellular pH regulation in primary rat astrocytes and C6 glioma cells
L. Shrode (1994)
10.1007/BF01849103
Über den K- und Ca-Gehalt von Eiter und Exsudaten und Seine Beziehungen zum Entzündungsschmerz
C. Häbler (2005)
10.1038/sj.bjp.0704113
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen
S. Holt (2001)
10.1016/S0024-3205(98)00052-6
Distribution and characterization of anandamide amidohydrolase in mouse brain and liver.
K. Watanabe (1998)
10.1074/jbc.270.40.23823
Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide (*)
N. Ueda (1995)
10.1523/JNEUROSCI.21-20-08026.2001
Nonsteroid Anti-Inflammatory Drugs Inhibit Both the Activity and the Inflammation-Induced Expression of Acid-Sensing Ion Channels in Nociceptors
N. Voilley (2001)
10.1023/A:1005996816453
Sensitization to hyperthermia by intracellular acidification
R. Kitai (2004)
10.1053/eujp.2000.0173
Plasma levels after peroral and topical ibuprofen and effects upon low pH‐induced cutaneous and muscle pain
A. Steen (2000)
10.1016/S0731-7085(98)00235-0
PH-metric log P 11. pKa determination of water-insoluble drugs in organic solvent-water mixtures.
A. Avdeef (1999)
10.1038/sj.bjp.0704199
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide
K. Jonsson (2001)
10.1016/0006-2952(93)90486-G
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.
D. Deutsch (1993)
10.1016/S0083-6729(01)62002-8
Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides.
M. Patricelli (2001)
10.1126/SCIENCE.277.5329.1094
Functional role of high-affinity anandamide transport, as revealed by selective inhibition.
M. Beltramo (1997)
10.1016/0014-5793(95)01311-3
Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’
S. Maurelli (1995)
Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.
F. Rakhshan (2000)
10.1016/S0006-2952(99)00373-1
Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate.
G. Tiger (2000)
10.1016/S0304-3940(98)00700-9
Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry
K. Tsou (1998)
Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship.
C. Fowler (1997)
10.7551/mitpress/10457.003.0010
Cannabinoids and pain.
I. Lever (2001)
10.1021/BI00578A012
Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ.
J. A. Thomas (1979)
10.2174/0929867023370707
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
D. Lambert (2002)
10.1111/j.1471-4159.1984.tb12750.x
Catabolism of N‐Acylethanolamine Phospholipids by Dog Brain Preparations
V. Natarajan (1984)
Pharmacokinetics of ibuprofen in man: a single-dose comparison of two over-the-counter, 200 mg preparations.
P. Karttunen (1990)
10.1006/ABBI.1998.1025
Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.
C. Fowler (1999)
10.1124/MOL.59.6.1369
Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.
T. Day (2001)
10.1080/1475636021000049726
Acidic Nonsteroidal Anti-inflammatory Drugs Inhibit Rat Brain Fatty Acid Amide Hydrolase in a pH-dependent Manner
C. Fowler (2003)
10.1021/BI981733N
Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization.
M. Patricelli (1998)
10.1002/(SICI)1099-081X(199608)17:6<511::AID-BDD969>3.0.CO;2-Y
The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
A. Pargal (1996)
10.1038/sj.bjp.0704029
Characterization of palmitoylethanolamide transport in mouse Neuro‐2a neuroblastoma and rat RBL‐2H3 basophilic leukaemia cells: comparison with anandamide
S. O. Jacobsson (2001)
10.1016/s0021-9258(17)38695-7
Properties of rat liver N-acylethanolamine amidohydrolase.
P. Schmid (1985)
Tissue and intracellular pH in normal periarticular soft tissue and during different phases of antigen induced arthritis in the rat.
S. E. Andersson (1999)
Analgesic - antipyretic and antiinflammatory agents and drugs employed in the treatment of gout
LJ Roberts (2001)
10.1523/JNEUROSCI.12-01-00086.1992
Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro
K. Steen (1992)
10.1074/jbc.272.6.3315
Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes*
T. Bisogno (1997)
10.1007/978-3-540-33823-9_10
Cannabinoids and pain.
A. Rice (2001)
10.1002/(SICI)1098-2795(199610)45:2<183::AID-MRD11>3.0.CO;2-2
The uterus is a potential site for anandamide synthesis and hydrolysis: Differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period
B. Paria (1996)
10.1074/jbc.M003161200
The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase*
D. Deutsch (2001)



This paper is referenced by
10.4274/balkanmedj.galenos.2020.2020.6.66
Non-opioid Analgesics and the Endocannabinoid System
R. D. Topuz (2020)
10.1371/journal.pone.0103589
Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen
Jessica Karlsson (2014)
Endocannabinoid metabolism : the impact of inflammatory factors and pharmacological inhibitors
Jessica Karlsson (2018)
10.1016/j.pain.2009.08.013
Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids
A. Telleria-Diaz (2010)
10.1016/J.EJPHAR.2007.02.051
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
S. Holt (2007)
10.1007/s00210-006-0044-7
Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?
I. Tegeder (2006)
10.1016/J.EJPHAR.2004.03.048
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
C. Fowler (2004)
10.1016/j.neuropharm.2013.03.021
Anandamide deficiency and heightened neuropathic pain in aged mice
P. Bishay (2013)
10.1016/J.TIPS.2003.12.001
Possible involvement of the endocannabinoid system in the actions of three clinically used drugs.
C. Fowler (2004)
10.15252/emmm.201404168
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
K. Schmitz (2014)
10.1038/sj.bjp.0707352
Interaction of ligands for the peroxisome proliferator‐activated receptor γ with the endocannabinoid system
A. Lenman (2007)
10.1016/j.tips.2012.05.003
NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?
C. Fowler (2012)
10.1021/JM058183T
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
D. Lambert (2005)
10.1016/J.EJPS.2004.03.009
Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments.
M. Karlsson (2004)
10.1111/J.1742-7843.2006.PTO_376.X
The endocannabinoid system: current pharmacological research and therapeutic possibilities.
Kent-Olov Jonsson (2006)
10.2174/1874467210902010001
Targeting the Androgen Receptor by Taxol in Castration-Resistant Prostate Cancer.
Jingting Jiang (2010)
10.3892/etm.2014.2101
Effect of α-tocopheryl succinate on the molecular damage induced by indomethacin in C6 glioma cells
Murat Pekmez (2015)
10.2174/1874467210902010001
Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.
M. Hamza (2009)
The cellular processing of the endocannabinoid anandamide and its pharmacological manipulation
L. Thors (2009)
10.2174/157015906778019527
Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.
J. Manzanares (2006)
10.3109/14756366.2011.643304
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide
C. Fowler (2013)
10.1016/J.PHRS.2006.07.006
The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH.
Ben Paylor (2006)
10.1111/j.1476-5381.2008.00029.x
The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1
C. Fowler (2009)
Semantic Scholar Logo Some data provided by SemanticScholar